Late Breaking Abstract - Daily physical activity in patients with severe asthma and the effect of anti-IL5 therapy

被引：2
|
作者：
Panagiotou, Marios [1 ]
Koulouris, Nikolaos [1 ]
Koutsoukou, Antonia [1 ]
Tsami, Maria [2 ]
Syrigou, Ekaterini [3 ]
Rovina, Nikoletta [1 ]
机构：
[1] Univ Athens, Dept Resp Med 1, Sotiria Thorac Dis Gen Hosp, Athens, Greece
[2] Sotiria Gen Hosp, Dept Allergy & Clin Immunol, Athens, Greece
[3] Sotiria Gen Hosp, Dept Allergy & Clin Immunol, Athens, Greece
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 54卷
关键词：
Asthma; -; management; Physical activity; Adults;
D O I：
10.1183/13993003.congress-2019.PA1648
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1648
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Reply to "Anti-IL5/IL5R switching between biologics in patients with severe eosinophilic asthma''
    Eger, Katrien
    Kroes, Johannes A.
    ten Brinke, Anneke
    Bel, Elisabeth H.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1936 - 1936
  • [22] The impact of anti-IL5 therapies in allergic patients with severe asthma, with and without fungal sensitization
    Colque-Bayona, M.
    Concha Llona, I. Fernandez
    Laorden Escudero, D.
    Losantos Garcia, I.
    Navarro-Cascales, T.
    Dominguez-Ortega, J.
    ALLERGY, 2023, 78
  • [23] Sputum cytokines associated with raised FeNO after anti-IL5 biologic therapy in severe asthma
    Hekking, Pieter-Paul
    Zhang, Kayla
    Garrido, Carmen Paz Venegas
    Lopez-Rodriguez, Raquel
    Kjarsgaard, Melanie
    Mukherjee, Manali
    Nair, Parameswaran
    ALLERGY, 2024, 79 (08) : 2244 - 2247
  • [24] An audit of anti-IL5 therapy in a severe asthma clinic at Mercy University Hospital (MUH), Cork
    O'Connor, B.
    Curran, D. R.
    O'Connor, T. M.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2019, 188 (SUPPL 10) : 265 - 265
  • [25] Effect of anti-IL5 treatment on symptoms of chronic rhinosinusitis, otitis and hearing loss in patients with severe eosinophilic asthma
    Wiegman, Mirjam I.
    Kroes, Johannes A.
    Van der Meer, Akke-Nynke
    Gijtenbeek, Rolof G. P.
    Jong, Kim De
    Ten Brinke, Anneke
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54
  • [26] EFFECTIVENESS OF ANTI-IL4R THERAPY FOLLOWING SUBOPTIMAL RESPONSE TO ANTI-IL5/5R THERAPY IN SEVERE EOSINOPHILIC ASTHMA
    Mason, T. W.
    Hearn, A. P.
    d'Ancona, G.
    Fernandes, M.
    Roxas, C.
    Green, L.
    Thomson, L.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    THORAX, 2021, 76 : A177 - A178
  • [27] Effectiveness of Anti-IL4R Therapy Following Suboptimal Response to Anti-IL5/5R Therapy in Severe Eosinophilic Asthma
    Mason, T.
    Hearn, A. P.
    d'Ancona, G.
    Fernandes, M.
    Green, L.
    Roxas, C.
    Thomson, L.
    Dhariwal, J.
    Nanzer, A. M.
    Jackson, D. J.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [28] The effect of anti-IL5 monoclonal antibodies on regulatory and effector T cells in severe eosinophilic asthma
    Bergantini, Laura
    Pianigiani, Tommaso
    d'Alessandro, Miriana
    Gangi, Sara
    Cekorja, Behar
    Bargagli, Elena
    Cameli, Paolo
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 166
  • [29] Late Breaking Abstract - Two-year cumulative oral corticosteroid exposure in severe eosinophilic asthma before and after anti-IL-5 therapy
    Kroes, Johannes A.
    Zielhuis, Sybrand W. J.
    De Jong, Kim
    Zielhuis, Sander W.
    Van Roon, Eric N.
    Bel, Elisabeth H. D.
    Ten Brinke, Anneke
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [30] Effect of Anti-IL5, Anti-IL5R, Anti-IL13 Therapy on Asthma Exacerbations: A Network Meta-analysis
    Ramonell, Richard P.
    Iftikhar, Imran H.
    LUNG, 2020, 198 (01) : 95 - 103
12345